It protects from liver fibrosis (Tsuda et al., 2013) since it reverses TGF-β-stimulated EMT, a fact demonstrated by the reduction of liver damage associated markers such as ALT and AST, of cellular collagen and reactive oxygen species (ROS) levels (Wei et al., 2018). This evidence concerns the gene TGFB1 and Hepatic fibrosis.